Inhibition of LSD1 in TGF-β-stimulated fibroblasts reduced the levels of total SMAD3, suggesting LSD1 is important for regulating SMAD3 expression, leading to changes in pSMAD3 levels when SSc dermal fibroblasts are stimulated with TGF-β. Here, SMAD3 is linked to systemic sclerosis.